The chronic pain pipeline looks promising with the emerging therapies including QULIPTA, ZILOSUL, TNX-102, reboxetine, CNTX-4975, CINGAL, dronabinol, buprenorphine, RTX-GRT7039, HP-5000, fasinumab, BIIB074, and others.